Medical Communications

Researchers from Cambridge University and The Alan Turing Institute have developed an artificial intelligence (AI) system that can diagnose dementia …

Researchers from Chalmers University of Technology, Sweden, have developed a new method to prevent bacterial infections relating to medical implants …

AstraZeneca has announced the EU approval of Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, alongside a licence extension from …

Under a new agreement announced on Friday, AstraZeneca will licence AZD5153, a potent and selective BRD4 BET inhibitor with a …

Gilead have released a statement warning of tampered and counterfeit versions of its once-daily single tablet HIV treatment regimen Biktarvy …

The Phase III trial of Sanofi and Regeneron’s PD-1 inhibitor Libtayo in combination with platinum-doublet chemotherapy was stopped early due …

The FDA has granted Apexigen’s sotigalimab (APX005M) Orphan Drug Designation for the treatment of soft tissue sarcoma.Sotigalimab, Apexigen’s lead therapeutic …

A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce COVID infections by …

Treating COVID patients with acute respiratory failure with continuous positive airway pressure (CPAP) reduces the need for invasive mechanical ventilation, …

Japan has warned that COVID-19 cases are surging at an ‘unprecedented pace’, hitting record highs in Tokyo amid the Olympic …

On Wednesday China reported the highest number of new locally transmitted COVID-19 cases since January, with case numbers being driven …

Novartis has announced that it will launch a new Phase III study to expand the use of Zolgensma – the …

The NHS alongside cancer charities are set to launch a clinical trial to investigate the effects of a cannabis-based oral …

The CMA has fined the pharmaceutical company Advanz over £100 million after it charged excessive and unfair prices for supplying …

Viatris has become the first company to secure FDA approval for a biosimilar product that is considered completely interchangeable with …